NMN New Clinical Finding: Obvious NAD(H) Level Increase
Paid for and content provided by Effepharm Ltd
With 7.3% CAGR, The "Nicotinamide Mononucleotide (NMN) Market" size is expected to grow from 194.2 million USD In 2020, to reach 296.5 Million USD by 2026.”